return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Board of Directors
Management Team
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Media Centre
Overview
Newsletters
Coverage
Investor Videos
NOX Insights
Noxopharm Podcasts
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
14-Dec-2021
Noxopharm DARRT-2 Cancer Trial Update
2-Dec-2021
Notification of cessation of securities - NOX
2-Dec-2021
Change of Director's Interest Notice - GK
17-Nov-2021
Noxopharm Annual General Meeting Results
17-Nov-2021
Licencing Deal Expands Noxopharm Drug Opportunities
17-Nov-2021
Noxopharm 2021 AGM Corporate Presentation
17-Nov-2021
Noxopharm 2021 AGM Chairmans Address
16-Nov-2021
Retraction of Grant Announcement
15-Nov-2021
Trading Halt
15-Nov-2021
Noxopharm Awarded A$8.8M Aust Govt Grant for Sarcoma Trial
1
2
3
4
5
6
7
8
9
10
11
12
Next
